[1]
N. Nikbakhsh, “Effectiveness of escitalopram in the reduction of pain, anxiety, and depression in patients with breast cancer: A randomized single-blind controlled trial”, Iran. Red. Crescent. Med. J., vol. 23, no. 7, Aug. 2021.